| Haplo Peripheral Blood Sct In GVHD Prevention (NCT04473911) | Zachariah Michael DeFilipp | 2020-08-14 |
| Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms. (NCT03869476) | University Hospital, Angers | 2019-07-30 |
| Aprepitant Versus Hydroxyzine in Persistent Aquagenic Pruritus for Patients With Myeloproliferative Neoplasms (NCT03808805) | University Hospital, Brest | 2019-04-16 |
| Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning (NCT03852407) | University of Liege | 2019-02-04 |
| Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation (NCT03734601) | Stanford University | 2018-11-05 |
| The NUTRIENT Trial (NUTRitional Intervention Among myEloproliferative Neoplasms): Feasibility Phase (NCT03907436) | University of California, Irvine | 2018-10-01 |
| Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression (NCT03480360) | Dartmouth-Hitchcock Medical Center | 2018-03-28 |
| Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT) (NCT03149055) | Memorial Sloan Kettering Cancer Center | 2017-05-04 |
| Clinical Characteristics of Aquagenic Pruritus in Patients With Myeloproliferative Neoplasms (NCT03688490) | University Hospital, Brest | 2013-07-17 |
| Preventing Stem Cell Transplant Complications With a Blood Separator Machine (NCT01866839) | National Heart, Lung, and Blood Institute (NHLBI) | 2013-05-29 |
| Early Recognition of Pulmonary Arterial Hypertension in Myelodysplastic and Myeloproliferative Diseases (NCT00909467) | Medical University of Graz | 2009-04-01 |
| Evaluation of Formin Gene Status and Expression in Myeloproliferative and Myelodysplastic Disorders (NCT00687414) | Corewell Health West | 2008-04-01 |
| Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD (NCT00539695) | Baylor College of Medicine | 2007-06-01 |
| Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma (NCT00588666) | Memorial Sloan Kettering Cancer Center | 2006-05-01 |
| Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders (NCT00533923) | Beth Israel Deaconess Medical Center | 2002-12-01 |
| T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies (NCT00683046) | University of Chicago | 2001-11-01 |
| Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies (NCT01499147) | University of Illinois at Chicago | 2000-02-01 |
| Primary Thrombocythaemia 1 Trial (NCT00175838) | University of Cambridge | 1997-07-01 |